BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
6/12/2026 6:20:01 AM | Browse: 1 | Download: 0
 |
Received |
|
2026-02-07 03:17 |
|
Peer-Review Started |
|
2026-02-07 03:17 |
|
First Decision by Editorial Office Director |
|
2026-02-28 06:50 |
|
Return for Revision |
|
2026-02-28 22:02 |
|
Revised |
|
2026-03-08 20:40 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2026-03-19 02:33 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2026-03-19 09:51 |
|
Articles in Press |
|
2026-03-19 09:51 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2026-05-29 05:23 |
|
Publish the Manuscript Online |
|
2026-06-12 06:20 |
| ISSN |
2308-3840 (online) |
| Open Access |
Open-Access: This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc. |
| Copyright |
©Author(s) (or their employer(s)) 2026. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Cardiac & Cardiovascular Systems |
| Manuscript Type |
Meta-Analysis |
| Article Title |
Glucagon-like peptide-1-based incretin agonists in obesity-related heart failure with preserved ejection fraction: A systematic review and meta-analysis
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Ehab Al Mashtoub, Ali Hteit, Anthony Bedran, Janette Al Banna, Charbel El Hachem, Nazih Obeid, Mostafa Msheik, Mohamad Tlais and Razan Abdulaal |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Mohamad Tlais, MD, Cardiology, University of Balamand, Hazmieh, Beirut 1100, Beyrouth, Lebanon. mmtlaiss22@gmail.com |
| Key Words |
Heart failure with preserved ejection fraction; Obesity-related heart failure with preserved ejection fraction; Glucagon-like peptide-1 receptor agonists; Dual GIP/GLP-1 receptor agonist; Incretin agonists; Semaglutide; Tirzepatide; Weight loss; Meta-analysis; Systematic review |
| Core Tip |
Glucagon-like peptide-1 (GLP)-1-based incretin agonists, including semaglutide and the dual GIP/GLP-1 receptor agonist tirzepatide, produce consistent and clinically meaningful improvements in symptoms, functional capacity, and body weight in patients with obesity-related heart failure with preserved ejection fraction. Tirzepatide additionally reduced the composite of cardiovascular death or worsening heart failure events, establishing weight-centric pharmacotherapy as a promising disease-modifying strategy for this high-risk and previously treatment-resistant phenotype. |
| Publish Date |
2026-06-12 06:20 |
| Citation |
Al Mashtoub E, Hteit A, Bedran A, Al Banna J, El Hachem C, Obeid N, Msheik M, Tlais M, Abdulaal R. Glucagon-like peptide-1-based incretin agonists in obesity-related heart failure with preserved ejection fraction: A systematic review and meta-analysis. World J Meta-Anal 2026; 14(2): 119849
|
| URL |
https://www.wjgnet.com/2308-3840/full/v14/i2/119849.htm |
| DOI |
https://doi.org/10.13105/wjma.v14.i2.119849 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
